Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
David R. Martinez, Alexandra Schäfer, Sarah R. Leist, et al.
Science (2021) Vol. 373, Iss. 6558, pp. 991-998
Open Access | Times Cited: 177

Showing 51-75 of 177 citing articles:

Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination
Eric S. Geanes, Cas LeMaster, Elizabeth Fraley, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2
Yu Liang, Jing Zhang, Run Yu Yuan, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 31
Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies
Gautam Sanyal
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 31
Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development
Julie Bigay, Roger Le Grand, Frédéric Martinon, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 29
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy
Penny L. Moore, T. Leighton, Julie Ostrowsky, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2101-2112
Open Access | Times Cited: 19
Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus
Jimin Lee, Samantha K. Zepeda, Young‐Jun Park, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 12, pp. 1961-1973.e11
Open Access | Times Cited: 18
Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development
Xuemei He, Cai He, Weiqi Hong, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 932-971
Open Access | Times Cited: 17
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses
Sneha Vishwanath, George Carnell, Matteo Ferrari, et al.
Nature Biomedical Engineering (2023)
Open Access | Times Cited: 16
Challenges in Emerging Vaccines and Future Promising Candidates against SARS-CoV-2 Variants
Tanmay Ghildiyal, Nishant Rai, Janhvi Mishra Rawat, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-19
Open Access | Times Cited: 6
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses
David R. Martinez, Fernando R. Moreira, Nicholas Catanzaro, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 748
Open Access | Times Cited: 5
Structural and functional properties of the SARS-CoV-2 spike protein: Potential vaccine and drug development for COVID-19
Reed L. Berkowitz, David A. Ostrov
Elsevier eBooks (2025), pp. 57-74
Closed Access
Structural prediction of chimeric immunogen candidates to elicit targeted antibodies against betacoronaviruses
Jamel Simpson, Peter M. Kasson
PLoS Computational Biology (2025) Vol. 21, Iss. 2, pp. e1012812-e1012812
Open Access
Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens
Yen Thi Kim Nguyen, Xueyong Zhu, Julianna Han, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 7
Open Access
Targeted delivery of TGF-β mRNA to murine lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers
Jaclynn A Meshanni, Emily Stevenson, Dapeng Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Protein engineering strategies for rational immunogen design
Timothy M. Caradonna, Aaron G. Schmidt
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 39
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting
Blake M. Hauser, Maya Sangesland, Kerri St. Denis, et al.
Cell Reports (2022) Vol. 38, Iss. 12, pp. 110561-110561
Open Access | Times Cited: 25
A Bivalent COVID-19 Vaccine Based on Alpha and Beta Variants Elicits Potent and Broad Immune Responses in Mice against SARS-CoV-2 Variants
Rui Wang, Chunyun Sun, Juan Ma, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 702-702
Open Access | Times Cited: 24
Sequence determinants of human-cell entry identified in ACE2-independent bat sarbecoviruses: A combined laboratory and computational network science approach
Ehdieh Khaledian, Sinem Ulusan, Jeffery A. Erickson, et al.
EBioMedicine (2022) Vol. 79, pp. 103990-103990
Open Access | Times Cited: 23
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera
Geoffrey B. Hutchinson, Olubukola M. Abiona, Cynthia T. Ziwawo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Targeting neuraminidase: the next frontier for broadly protective influenza vaccines
Nicholas C. Wu, Ali H. Ellebedy
Trends in Immunology (2023) Vol. 45, Iss. 1, pp. 11-19
Closed Access | Times Cited: 13
A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity
Ellen Young, Boyd L. Yount, Petraleigh Pantoja, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
A spike virosome vaccine induces pan-sarbecovirus antibody responses in mice
Mitch Brinkkemper, Meliawati Poniman, Esther Siteur-van Rijnstra, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109719-109719
Open Access | Times Cited: 4
mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies
Brian Montoya, Carolina R. Melo‐Silva, Lingjuan Tang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1790-1804
Open Access | Times Cited: 4
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 29
Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines
Jie Zhou, Zezhong Liu, Guangxu Zhang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 21

Scroll to top